Skip to main content
. 2020 Jul 28;17(7):410–416. doi: 10.11909/j.issn.1671-5411.2020.07.004

1.

Characteristics of the participants (n = 100).

Characteristics Mean ± SD or %
*The data of 1 participant is missing for NYHA functional class. ADL: activities of daily living; BMI: body mass index; CRP: C-reactive protein; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; IADL: instrumental activities of daily living; MNA: mini nutritional assessment; NHYA: New York Heart Association functional class; SPPB: short physical performance battery.
Age, yrs 79.3 ± 6.7
Men 59%
Number of medications 7.8 ± 2.9
Charlson Index 2.9 ± 1.9
Type 2 diabetes 21%
Valve heart disease 74%
Arrhythmia 61%
Coronary heart disease 49%
Heart failure 45
NYHA functional class*
  Ⅰ / Ⅱ 57%
  Ⅲ / Ⅳ 42%
ADL (/6) 5.8 ± 0.5
IADL (/4) 3.7 ± 0.6
Weight (kg) 72.9 ± 14.3
BMI (kg/m2) 26.3 ± 5.0
MNA score 22.8 ± 3.1
   < 17 3%
  17–23.5 57%
  ≥ 24 40%
Lifetime max weight – actual (kg) 7.6 ± 6.9
Albuminemia (g/l) 37.6 ± 5.1
CRP (mg/l) 11 ± 19
Handgrip strength 23.6 ± 9.4
SPPB score /12 7.7 ± 3.0
  9–12 49%
  0–8 51%
Walking speed, m/s 0.84 ± 0.31
Fried fraily phenotype (/5) 2.3 ± 1.4
EORTC QLQ-C30 score (/112) 51.2 ± 14.6
Perceived global health score (/7) 4.1 ± 1.3
Perceived quality of life score (/7) 4.7 ± 1.5